Sign In
Buy ONCY
$0.94
+0.0237 (+2.58%)
At Close: Jun 23, 2026
Oncolytics Biotech® Reports 2020 Second Quarter Financial Results and Operational Highlights
08:01pm, Tuesday, 04'th Aug 2020
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced its financial results and operational highlights for the quarter ended June 30, 2020. All dollar amounts are expressed in Canadian c
SAN DIEGO and CALGARY, Alberta , June 25, 2020 /CNW/ -- Oncolytics Biotech® Inc. (ONCY) (ONC.TO), today announced a new investigator-sponsored triple-negative breast cancer (TNBC) study to be ma
Oncolytics Biotech® Doses First Patient in Phase 2 BRACELET-1 Study Evaluating Pelareorep-Based Combination Therapies in Metastatic Breast Cancer
Oncolytics Biotech® Establishes New At-The-Market Facility
12:15am, Tuesday, 16'th Jun 2020
SAN DIEGO, Calif. and CALGARY, Alberta , June 15, 2020 /CNW/ -- Oncolytics Biotech® Inc. (ONCY) (ONC.TO), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, tod
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today provided a recap of a Key Opinion Leader (KOL) call sponsored by Canaccord Genuity and held on June 2, 2020. The call focused on recently ann
Oncolytics Highlights Presentation Of Clinical Proof-Of-Concept Data In Multiple Myeloma At ASCO
11:10am, Friday, 29'th May 2020Oncolytics Biotech® Presents Clinical Proof-of-Concept Data in Multiple Myeloma at the ASCO Virtual Annual Meeting
11:00am, Friday, 29'th May 2020
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced the publication of an electronic-poster (ePoste
SAN DIEGO and CALGARY, Alberta , May 26, 2020 /CNW/ -- Oncolytics Biotech® Inc. (ONCY) (ONC.TO), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announc
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
12:00am, Sunday, 24'th May 2020
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector.
Surface Oncology Inc (...
